Press Release : Global Heart Hub and Novartis -2-

As a leading global medicines company, we use innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews

For Novartis multimedia content, please visit https://www.novartis.com/news/media-library https://www.novartis.com/news/media-library

For questions about the site or required registration, please contact [e-mail]

References

   1. Roth GA, Mensah GA, Johnson CO, et al. Global Burden of Cardiovascular 
      Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study 
      [published correction appears in J Am Coll Cardiol. 
      2021;77(15):1958-1959]. J Am Coll Cardiol. 2020;76(25):2982-3021. 
 
   2. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic 
      Burden of Noncommunicable Diseases. Geneva: World Economic Forum. 2011. 
 
   3. World Health Organization (WHO). Cardiovascular diseases (CVDs). 
      Available at: 
      https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases- 
      (cvds). [Last accessed October 2021]. 
 
   4. Barquera S, Pedroza-Tobías A, Medina C, et al. Global Overview of 
      the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res. 
      2015;46(5):328-338. 
 
   5. Mayo Clinic. Arteriosclerosis / atherosclerosis. Available at: 
      https://www.mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/symptoms-causes/syc-20350569. 
      [Last accessed October 2021]. 
 
   6. Goldstein J, Brown M. A century of cholesterol and coronaries: from 
      plaques to genes to statins. Cell. 2015;161(1):161-172. 
 
   7. OECD/The King's Fund. Is Cardiovascular Disease Slowing Improvements in 
      Life Expectancy?: OECD and The King's Fund Workshop Proceedings. OECD 
      Publishing, Paris. 2020. 
 
   8. World Health Organization (WHO). Noncommunicable diseases. Available at: 
      https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. 
      [Last accessed October 2021]. 
 
   9. Ray K, Wright R, Kallend D, et al. Two Phase 3 Trials of Inclisiran in 
      Patients with Elevated LDL Cholesterol. N Engl J Med. 
      2020;382(16):1507-1519. 
 
  10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, 
      Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult 
      Treatment Panel III). Third Report of the National Cholesterol Education 
      Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of 
      High Blood Cholesterol in Adults (Adult Treatment Panel III) final 
      report. Circulation. 2002;106(25):3143-3421. 
 
  11. National Kidney Foundation. Global Facts: About Kidney Disease. Available 
      at: 
      https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease. 
      [Last accessed October 2021]. 
 
  12. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global 
      public health problem: approaches and initiatives -- a position statement 
      from Kidney Disease Improving Global Outcomes. Kidney Int. 
      2007;72(3):247-259. 
 
  13. World Health Organization. Diabetes. Available at: 
      https://www.who.int/news-room/fact-sheets/detail/diabetes. [Last accessed 
      October 2021]. 
 
  14. American Cancer Society. Global Cancer Facts & Figures 4th Edition. 
      Available at: 
      https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-4th-edition.pdf. 
      [Last accessed October 2021]. 
 
  15. World Health Organization (WHO). Cardiovascular diseases - Data and 
      statistics. 
      https://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics. 
      [Last accessed October 2021]. 

# # #

Novartis Media Relations

E-mail: [e-mail]

 
Richard Jarvis                        Phil McNamara 
 Novartis External Communications      Global Head, Cardio-Renal-Metabolism Communications 
 [phone] (mobile)              [phone] (mobile) 
 [e-mail]           [e-mail] 
 Julie Masow                           Jamie Bennett 
 Novartis US External Communications   Director, US External Engagement 
 [phone]                       [phone] 
 [e-mail]              [e-mail] 
 

Novartis Investor Relations

Central investor relations line: [phone]

E-mail: [e-mail]

 
Central                                 North America 
Samir Shah             [phone]  Sloan Simpson  [phone] 
Thomas Hungerbuehler   [phone]  Alina Levchuk  [phone] 
Isabella Zinck         [phone]  Parag Mahanti  [phone] 
 
 
 

(END) Dow Jones Newswires

October 19, 2021 01:15 ET (05:15 GMT)